We Are on the Verge of Breakthrough Cures for Type 1 Diabetes, but Who Are the 2 Million Americans Who Have It? [0.03%]
I型糖尿病患者突破性治愈近在眼前，但200万患者的境况如何？
Rebecca Smith,Samara Eisenberg,Aaron Turner-Pfifer et al.
Rebecca Smith et al.
Background: Two million Americans have type 1 diabetes (T1DM). Innovative treatments have standardized insulin delivery and improved outcomes for patients, but patients' access to such technologies depends on social determinants of health, ...
Assessing the Fiscal Burden of Overweight and Obesity in Japan through Application of a Public Economic Framework [0.03%]
运用公共经济学框架评估日本肥胖人口的财政负担
Ataru Igarashi,Cillian Copeland,Nikos Kotsopoulos et al.
Ataru Igarashi et al.
Introduction: Obesity continues to represent a significant public health concern, with a broad impact from both a health and economic perspective. Objective: This analysis assesses the fiscal consequences of overweight and obesity (OAO) in ...
Healthcare Resource Utilization Among Patients With Agitation in Alzheimer Dementia [0.03%]
阿茨海默病患者躁动引发的医疗资源利用状况研究
Christie Teigland,Zulkarnain Pulungan,David Bruhn et al.
Christie Teigland et al.
Background: Agitation in Alzheimer dementia is common, but the associated healthcare burden remains unclear. Objective: This retrospective analysis evaluated baseline characteristics, healthcare resource utilization, and costs among patient...
Real-World HbA1c Changes Among Type 2 Diabetes Mellitus Patients Initiating Treatment With a 1.0 Mg Weekly Dose of Semaglutide for Diabetes [0.03%]
司美格鲁肽一周一次1.0毫克剂量治疗2型糖尿病患者对糖化血红蛋白的影响：真实世界数据研究
Noelle N Gronroos,Caroline Swift,Monica S Frazer et al.
Noelle N Gronroos et al.
Background: Medical management of patients with type 2 diabetes mellitus (T2DM) is complex because of the chronic nature of the disease and its associated comorbidities. Injectable once-weekly semaglutide for diabetes (OW sema T2D) is a typ...
Costs of Potential Medication Wastage Due to Switching Treatment Among People With Multiple Sclerosis [0.03%]
多发性硬化患者换药造成的潜在药物浪费的成本分析
Darin T Okuda,Achal Patel,Robert Schuldt et al.
Darin T Okuda et al.
Background: Unused medications negatively impact healthcare resource utilization and environmental safety, contribute substantially to annual healthcare expenditures, and may ultimately affect patient health outcomes. People with multiple s...
Adherence to First-Line Intravesical Bacillus Calmette-Guérin Therapy in the Context of Guideline Recommendations for US Patients With High-Risk Non-muscle Invasive Bladder Cancer [0.03%]
美国高危非肌层浸润性膀胱癌患者一线卡介苗治疗的依从性研究及指南建议解读
Franklin D Gaylis,Bruno Emond,Ameur M Manceur et al.
Franklin D Gaylis et al.
Background: Bacillus Calmette-Guérin (BCG) can reduce recurrence and delay progression among patients with high-risk non-muscle invasive bladder cancer (NMIBC), but is associated with a substantial emotional, physical, and social burden. O...
Patient Experience of Living With Hemophilia A: A Conceptual Model of Humanistic and Symptomatic Experience in Adolescents, Adults, and Children [0.03%]
血友病A患者体验的人文及症状模型：青少年、成人和儿童患者的患病体验概念模型
Zalmai Hakimi,Rakhee Ghelani,Linda Bystrická et al.
Zalmai Hakimi et al.
Background: People living with hemophilia A face challenges impacting their daily lives despite treatment innovations. Previous studies have explored perceptions and treatment experiences; however, there is a lack of an evidence-based, comp...
Artificial Intelligence in Identifying Patients With Undiagnosed Nonalcoholic Steatohepatitis [0.03%]
人工智能在识别非酒精性脂肪肝未诊断患者中的应用
Onur Baser,Gabriela Samayoa,Nehir Yapar et al.
Onur Baser et al.
Background: Although increasing in prevalence, nonalcoholic steatohepatitis (NASH) is often undiagnosed in clinical practice. Objective: This study identified patients in the Veterans Affairs (VA) health system who likely had undiagnosed NA...
Health-Related Quality-of-Life Utility Values in Adults With Late-Onset Pompe Disease: Analyses of EQ-5D Data From the PROPEL Clinical Trial [0.03%]
关于晚发型庞贝病成人患者健康相关生命质量效用值的分析：PROPEL临床试验中EQ-5D数据的分析
Alasdair MacCulloch,Alison Griffiths,Neil Johnson et al.
Alasdair MacCulloch et al.
Background: Pompe disease is a rare lysosomal storage disorder, leading to accumulation of glycogen characterized by muscle weakness, fatigue, pain, and, in the longer term, a requirement for ventilatory and ambulatory support, and early mo...
Economic Evaluation of a Novel Treatment of Attention-Deficit/Hyperactivity Disorder in US Motor Vehicle Drivers [0.03%]
美国机动车驾驶员注意缺陷多动障碍新型治疗方法的经济评估
Jacie T Cooper,John E Schneider,Jim Potenziano et al.
Jacie T Cooper et al.
Background: Attention-deficit/hyperactivity disorder (ADHD) affects approximately 4.4% of US adults. ADHD is associated with high-risk driving behavior and costly motor vehicle accidents. DYANAVEL XR (DXR) (Tris Pharma, Inc.) is a once-dail...